ClinicalTrials.govpublic full text
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer
breast cancer, hla-a*0201, peptide vaccine, vegfr1, vegfr2, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 890134
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.